Clinical Evidence of Tirzepatide’s Cardiometabolic Benefits in Obesity
Tirzepatide cardiometabolic benefits extend beyond weight loss in obese non-diabetic adults. Clinical trials demonstrate improvements in blood pressure, lipid profiles, and inflammation. This evidence supports tirzepatide as a metabolic intervention…
Cannabinoids & Insulin Sensitivity
CED Clinical Relevance #62 Moderate Clinical Relevance Useful mechanistic human data, but not evidence that cannabis improves metabolism in everyday life. Clinical Insight | CED Clinic This cannabinoid insulin sensitivity study shows that cannabinoid…
How Cannabinoid Signaling Shapes Insulin Sensitivity in Humans
Cannabinoid receptor insulin sensitivity is explored in a controlled human trial using gold-standard metabolic clamp techniques. The findings show that CB1 receptor activity can shift insulin sensitivity without altering insulin secretion. This study…
GLP-1 Cardiovascular Outcomes: Metabolic Health Phenotypes
Metabolic health phenotypes influence cardiovascular outcomes beyond BMI alone. Understanding these phenotypes helps tailor GLP-1 therapy for better cardiometabolic risk management. This approach supports personalized treatment for patients with obesity…